Cargando…
Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer
The mortality rate of cervical cancer is the highest among female malignant tumors and seriously threatens women's lives and health. Persistent high-risk human papillomavirus (HPV) infection is the leading cause of cervical cancer, which provides the basis for immunotherapy. In recent years, ow...
Autores principales: | Li, Yang, Shen, Fangrong, Tan, Qingqing, Chen, Youguo, Gu, Yanzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621300/ https://www.ncbi.nlm.nih.gov/pubmed/37908109 http://dx.doi.org/10.1177/15330338231208846 |
Ejemplares similares
-
tRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1
por: Wang, Yang, et al.
Publicado: (2022) -
Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway
por: Wang, Juan, et al.
Publicado: (2021) -
Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies
por: Li, Yang, et al.
Publicado: (2023) -
Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression
por: Jiang, Rong, et al.
Publicado: (2021) -
Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer
por: Wang, Juan, et al.
Publicado: (2018)